
Adilios Life Science Private Limited
About Adilios Life Science Private Limited
Data last updated:
Adilios Life Science Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 07 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33100GJ2019PTC108027. Its GSTIN is 24AASCA2552J1ZI (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Hemalben Shaishav Patel and Urvi R Patel.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.68 Cr, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹4.31 Lakh (net margin 2.6%) and EBITDA of ₹6.2 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 44% over five years.
Adilios Life Science Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0067424).
Company details
Recognitions & Rankings of Adilios Life Science
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0067424
Contact details
Adilios Life Science Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop – 213 Nobles Trade Center Opp. B.D.Rao Hall Bhuyangdev Char Rasta, Memnagar, Ahmedabad, Gujarat, India – 380052
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Adilios Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adilios Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Adilios Life Science Private Limited, buy the company report.
Financials of Adilios Life Science Private Limited
FY 2025 filings availableAdilios Life Science Private Limited reported revenue of ₹1.68 Cr (up 52% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over five years, including 52% growth in the latest year. EBITDA fell 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adilios Life Science Private Limited, buy the company report.
Board of directors of Adilios Life Science Private Limited
Adilios Life Science has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemalben Shaishav Patel | Director | 16 Jun 2023 | 3 Years 5 Months | Current |
| Urvi R Patel | Director | 16 Jun 2023 | 3 Years 5 Months | Current |
| Pradipbhai Patel | Director | 07 May 2019 | 7 Years 6 Months | Current |
| Mayur Amichand Desai | Director | 07 May 2019 | 7 Years 6 Months | Current |
| Sulabh Binitkumar Mehta | Additional Director | 07 Jan 2026 | 0 Years 10 Months | Current |
| Piyushkumar Ishwarlal Patel | Additional Director | 12 Jan 2026 | 0 Years 10 Months | Current |
Peer comparison
Adilios Life Science Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ms Suraj Pharmaceuticals (India) Private Limited | ₹1.68 Cr (FY 2024) | -2.0% | Patna, Bihar, India | |||
| Saj Propack Private Limited | ₹1.68 Cr (FY 2025) | -23.0% | Kulgachia, West Bengal, India | |||
| Axon Laboratories Private Limited | ₹1.68 Cr (FY 2024) | 58.0% | Punjab, India | |||
| Blissbury Care Private Limited | ₹1.68 Cr (FY 2025) | 44.0% | Bhopal, Madhya Pradesh, India | |||
| Medibloom Pharmachem Private Limited | ₹1.68 Cr (FY 2024) | 11.0% | Baddi, Himachal Pradesh, India | |||
| Adilios Life Science Private Limitedthis company | ₹1.68 Cr (FY 2025) | ₹4.31 Lakh | 2.6% | 52.0% | Ahmedabad, Gujarat, India | |
| Medvey Biotech Private Limited | ₹1.68 Cr (FY 2024) | 118.0% | Kudus, Maharashtra, India | |||
| Bacs Research Lab Private Limited | ₹1.68 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Gamoxo Home Care Private Limited | ₹1.68 Cr (FY 2017) | Indore, Madhya Pradesh, India | ||||
| Yogi International Private Limited | ₹1.68 Cr (FY 2025) | 42.0% | Ahmedabad, Gujarat, India | |||
| Medfly Healthcare Private Limited | ₹1.68 Cr (FY 2024) | 35.0% | Pune, Maharashtra, India |
To see the full peer comparison of Adilios Life Science Private Limited, buy the company report.
Auditor
Adilios Life Science Private Limited is audited by DHIRAJLAL SHAH & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHIRAJLAL SHAH & CO. | FY 2022 | 148300W |
Shareholding
The shareholding of Adilios Life Science Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Adilios Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adilios Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adilios Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adilios Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AASCA2552J1ZI | Gujarat | Active | 07 Jun 2019 |
To see the full GST registrations and return filing status of Adilios Life Science Private Limited, buy the company report.
Recent activity
Adilios Life Science Private Limited has 12 board changes on record since 2019: 6 appointments and 6 cessations. The latest: Piyushkumar Ishwarlal Patel was appointed as Additional Director on 12 Jan 2026.
3 earlier events are in the company report.
Frequently asked questions
Adilios Life Science is an active private limited company based in Ahmedabad, Gujarat, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 07 May 2019 (7+ years old) and is registered under CIN U33100GJ2019PTC108027.
Adilios Life Science has 6 current directors:
- Hemalben Shaishav Patel - Director
- Urvi R Patel - Director
- Pradipbhai Patel - Director
- Mayur Amichand Desai - Director
- Sulabh Binitkumar Mehta - Additional Director
- Piyushkumar Ishwarlal Patel - Additional Director
The latest financial statements of Adilios Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Adilios Life Science is 24AASCA2552J1ZI, registered in Gujarat.
The CIN (Corporate Identification Number) of Adilios Life Science is U33100GJ2019PTC108027. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adilios Life Science was incorporated on 07 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Adilios Life Science by revenue are Ms Suraj Pharmaceuticals (India) Private Limited, Saj Propack Private Limited, Axon Laboratories Private Limited, Blissbury Care Private Limited, Medibloom Pharmachem Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Piyushkumar Ishwarlal Patel was appointed as Additional Director on 12 Jan 2026. Sulabh Binitkumar Mehta was appointed as Additional Director on 07 Jan 2026. Hemalben Shaishav Patel ceased to be Additional Director on 29 Sep 2023. Adilios Life Science has 12 board changes on record in total.
Yes, Adilios Life Science is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Adilios Life Science is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0067424).
The registered office of Adilios Life Science is at Shop – 213 Nobles Trade Center Opp. B.D.Rao Hall Bhuyangdev Char Rasta, Memnagar, Ahmedabad, Gujarat, India – 380052.

